Table 2.
Gd− (n = 20) | Gd + (n = 26) | ||||
---|---|---|---|---|---|
Median | Q1-Q3 | Median | Q1–Q3 | p value | |
miR-21 | 0.014 | 0.010–0.022 | 0.029 | 0.013–0.052 | 0.024 |
miR-146a | 0.065 | 0.031–0.136 | 0.135 | 0.082–0.239 | 0.016 |
miR-146b | 0.008 | 0.002–0.020 | 0.021 | 0.012–0.052 | 0.030 |
miR-155 | 0.007 | 0.002–0.016 | 0.011 | 0.006–0.019 | 0.163 |
miR-223 | 0.066 | 0.043–0.328 | 0.124 | 0.088–0.226 | 0.232 |
miR-320 | 0.038 | 0.010–0.048 | 0.042 | 0.026–0.087 | 0.271 |
miR-328 | 0.007 | 0.003–0.012 | 0.011 | 0.005–0.026 | 0.143 |
Gd− patients without gadolinium-enhanced lesions, Gd+ patients with gadolinium-enhanced lesions; Q1–Q3 first quartile–third quartile